VAERS reports by lot

GSK Hepatitis B lot H7RF2: VAERS reports

38 VAERS reports list lot H7RF2 as a GSK Hepatitis B vaccine, received between 2023-11-11 and 2026-03-19. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
38
Reports
0%
Marked serious
0
With a death outcome
17
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological725%
Dermatological (non-injection-site)621%
Injection-site / Local reaction518%
Allergic / Anaphylactic311%
Gastrointestinal311%
General / Systemic (non-local)311%
Autoimmune / Immune-mediated14%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
Texas5
Michigan4
California3
Illinois2
Virginia2
Kansas2
North Carolina2
Pennsylvania2
Florida2
Arizona2
Idaho1
Indiana1

Reports by month received

MonthReportsBar
2023-111
2023-121
2024-011
2024-024
2024-034
2024-046
2024-053
2024-063
2024-073
2024-084
2024-091
2025-021
2025-042
2025-081
2025-111
2026-021
2026-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby GSK Hepatitis B lots (A–Z): AZ2A3 · DK23D · H3SG9 · J477Y · M4B34 · P2443

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.